Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16714)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol 2014; 20(26): 8351-8363 [PMID: 25024594 DOI: 10.3748/wjg.v20.i26.8351] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8351.htm |
| Number | Citing Articles |
| 1 |
Alison J. Dawson, Eric S. Kilpatrick, Anne-Marie Coady, Abeer M. M. Elshewehy, Youssra Dakroury, Lina Ahmed, Stephen L. Atkin, Thozhukat Sathyapalan. Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. BMC Endocrine Disorders 2017; 17(1) doi: 10.1186/s12902-017-0194-2
|
| 2 |
Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak. The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women. Hepatology 2021; 74(6): 2988 doi: 10.1002/hep.32034
|
| 3 |
Giselle Adriana Abruzzese, María Florencia Heber, María José Ferrer, Silvana Rocío Ferreira, Aimé Florencia Silva, Alicia Beatriz Motta. Effects of in utero androgen excess and metformin treatment on hepatic functions. Molecular and Cellular Endocrinology 2019; 491: 110416 doi: 10.1016/j.mce.2019.03.006
|
| 4 |
Amna Subhan Butt, Jalpa Devi. Polycystic Ovary Syndrome. 2024; : 92 doi: 10.1016/B978-0-323-87932-3.00021-9
|
| 5 |
Qingling Wang, Da Zhou, Mingjie Wang, Mingyu Zhu, Peizhan Chen, Hu Li, Meng Lu, Xinxin Zhang, Xizhong Shen, Taotao Liu, Li Chen. A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.900794
|
| 6 |
Gashaw Abebe, Daniel Ayanaw, Tiget Ayelgn Mengstie, Gashaw Dessie, Tabarak Malik. Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. SAGE Open Medicine 2022; 10 doi: 10.1177/20503121221124762
|
| 7 |
Linda Kujanpää, Riikka K Arffman, Paula Pesonen, Elisa Hurskainen, Marjo-Riitta Järvelin, Stephen Franks, Juha S Tapanainen, Laure Morin-Papunen, Terhi T Piltonen. Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data. European Journal of Endocrinology 2024; 190(6): 409 doi: 10.1093/ejendo/lvae057
|
| 8 |
Nikolaos Nikolaou, Leanne Hodson, Jeremy W. Tomlinson. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. The Journal of Steroid Biochemistry and Molecular Biology 2021; 207: 105808 doi: 10.1016/j.jsbmb.2021.105808
|
| 9 |
Sinéad M. McGlacken-Byrne, Harriet M. Gunn, Helen Simpson. Paediatric Endocrinology. Endocrinology 2023; : 1 doi: 10.1007/978-3-030-18901-3_29-1
|
| 10 |
Bita Eslami, Najmeh Aletaha, Arezoo Maleki-Hajiagha, Mahdi Sepidarkish, Ashraf Moini. Evaluation of the predictive value of body mass index (BMI), waist circumference, and visceral fat to differentiate non-alcoholic fatty liver (NAFLD) in women with polycystic ovary syndrome. Journal of Research in Medical Sciences 2022; 27(1): 37 doi: 10.4103/jrms.JRMS_292_20
|
| 11 |
Emily L. Zumbro, Manisha Rao, Shenavia Balcom-Luker, K. Shane Broughton, Monique J. LeMieux. Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS). Nutrients 2021; 13(7): 2451 doi: 10.3390/nu13072451
|
| 12 |
Chao-Wu Xiao, Adriana A. Carbonel, Patricia D. A. Lima, Amy Hendry, Benjamin K. Tsang. Consumption of soya isoflavones improved polycystic ovary syndrome-associated metabolic disorders in a rat model. British Journal of Nutrition 2024; 132(4): 416 doi: 10.1017/S0007114524001296
|
| 13 |
Maja Milanović, Nataša Milošević, Jan Sudji, Stefan Stojanoski, Milica Atanacković Krstonošić, Artur Bjelica, Nataša Milić, Milica Medić Stojanoska. Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome?. Clinica Chimica Acta 2020; 507: 257 doi: 10.1016/j.cca.2020.05.009
|
| 14 |
Gulnara Novbatova, Kelsey Timme, Andrew Severin, Maryam Sayadi, Aileen F Keating. Maternal pre-conceptional glyphosate exposure impacts the offspring hepatic and ovarian proteome. Toxicological Sciences 2023; 194(1): 23 doi: 10.1093/toxsci/kfad047
|
| 15 |
|
| 16 |
Vasiliki Venetsanaki, Stergios A. Polyzos. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. Current Vascular Pharmacology 2019; 17(6): 546 doi: 10.2174/1570161116666180711121949
|
| 17 |
Oyekoya T Ayonrinde, Leon A Adams, Dorota A Doherty, Trevor A Mori, Lawrence J Beilin, Wendy H Oddy, Martha Hickey, Deborah M Sloboda, John K Olynyk, Roger Hart. Adverse metabolic phenotype of adolescent girls with non‐alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. Journal of Gastroenterology and Hepatology 2016; 31(5): 980 doi: 10.1111/jgh.13241
|
| 18 |
Krisztina Lajtai, Csilla Terézia Nagy, Róbert Tarszabó, Rita Benkő, Leila Hadjadj, Réka Eszter Sziva, Dóra Gerszi, Bálint Bányai, Péter Ferdinandy, György László Nádasy, Zoltán Giricz, Eszter Mária Horváth, Szabolcs Várbíró. Effects of Vitamin D Deficiency on Proliferation and Autophagy of Ovarian and Liver Tissues in a Rat Model of Polycystic Ovary Syndrome. Biomolecules 2019; 9(9): 471 doi: 10.3390/biom9090471
|
| 19 |
Myeong Jun Song, Jong Young Choi. Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1053709
|
| 20 |
Yong Chen, Leikai Ma, Zhouling Ge, Yizhao Pan, Lubin Xie. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.888194
|
| 21 |
Dong Liu, Xue Gao, Xiong-Fei Pan, Tao Zhou, Cairong Zhu, Fei Li, Jian-Gao Fan, Giovanni Targher, Jian Zhao. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-02775-0
|
| 22 |
Asieh Mansour, Maryam Mirahmad, Mohammad Reza Mohajeri-Tehrani, Mahdieh Jamalizadeh, Sedigheh Hosseinimousa, Fatemeh Rashidi, Pooria Asili, Sayed Mahmoud Sajjadi-Jazi. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-37513-2
|
| 23 |
Yasha V. Kameshwar, Gayatri Mishra. Inadvertent surgical bleeding in PCOS patient with splenomegaly and its association with Non Alcoholic Fatty Liver Disease (NAFLD). Journal of Anaesthesiology Clinical Pharmacology 2023; 39(4): 671 doi: 10.4103/joacp.joacp_188_22
|
| 24 |
Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan, Branka Filipović. Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6678142
|
| 25 |
Alekya Devi Anala, Insiya Sajjad Hussain Saifudeen, Maryam Ibrahim, Moksha Nanda, Nida Naaz, Stephen L. Atkin. The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome. Journal of Clinical Medicine 2023; 12(14): 4575 doi: 10.3390/jcm12144575
|
| 26 |
Elizabeth M. Brunt, Vincent W.-S. Wong, Valerio Nobili, Christopher P. Day, Silvia Sookoian, Jacquelyn J. Maher, Elisabetta Bugianesi, Claude B. Sirlin, Brent A. Neuschwander-Tetri, Mary E. Rinella. Nonalcoholic fatty liver disease. Nature Reviews Disease Primers 2015; 1(1) doi: 10.1038/nrdp.2015.80
|
| 27 |
Maryan G Rizk, Varykina G Thackray. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome. Journal of the Endocrine Society 2021; 5(2) doi: 10.1210/jendso/bvaa177
|
| 28 |
Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter. Sex‐specific aspects of venous thromboembolism: What is new and what is next?. Research and Practice in Thrombosis and Haemostasis 2022; 6(4): e12722 doi: 10.1002/rth2.12722
|
| 29 |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Extrahepatic complications of non-alcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(4): 472 doi: 10.1016/j.rgmxen.2019.05.004
|
| 30 |
Ioannis G. Lempesis, Samuel J. Apple, Gustavo Duarte, Leonidas Palaiodimos, Dimitrios Rafail Kalaitzopoulos, Maria Dalamaga, Damianos G. Kokkinidis. Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome. Diabetes/Metabolism Research and Reviews 2023; 39(6) doi: 10.1002/dmrr.3682
|
| 31 |
|
| 32 |
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2020; : 1 doi: 10.1007/978-3-319-66362-3_6-1
|
| 33 |
Evangeline Vassilatou, Sophia Lafoyianni, Dimitra Argyro Vassiliadi, Dimitrios Ioannidis, Stavroula A. Paschou, Maria Mizamtsidi, Maria Panagou, Andromachi Vryonidou. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome. Maturitas 2018; 116: 1 doi: 10.1016/j.maturitas.2018.06.013
|
| 34 |
Imaobong Inyang, Hunter E. White, Kelsey Timme, Aileen F. Keating. Biological sex differences in hepatic response to in utero dimethylbenz(a)anthracene exposure. Reproductive Toxicology 2024; 124: 108553 doi: 10.1016/j.reprotox.2024.108553
|
| 35 |
Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon, Sang Geon Kim. Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences 2023; 24(8): 7454 doi: 10.3390/ijms24087454
|
| 36 |
Stavroula A. Paschou, Stergios A. Polyzos, Panagiotis Anagnostis, Dimitrios G. Goulis, Christina Kanaka-Gantenbein, Irene Lambrinoudaki, Neoklis A. Georgopoulos, Andromachi Vryonidou. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Endocrine 2020; 67(1): 1 doi: 10.1007/s12020-019-02085-7
|
| 37 |
Maria Victoria Bazzano, Angela Köninger, Maria Emilia Solano. Immunologische Veränderungen beim Syndrom polyzystischer Ovarien. Gynäkologische Endokrinologie 2023; 21(4): 231 doi: 10.1007/s10304-023-00532-3
|
| 38 |
Łukasz Blukacz, Artur Nowak, Mariusz Wójtowicz, Angelika Krawczyk, Grzegorz Franik, Paweł Madej, Dagmara Pluta, Karolina Kowalczyk, Michał Żorniak. Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines 2022; 10(9): 2193 doi: 10.3390/biomedicines10092193
|
| 39 |
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
|
| 40 |
Sambit Roy, Aierken Abudu, Irving Salinas, Niharika Sinha, Holly Cline-Fedewa, Alexandra M Yaw, Wenjie Qi, Todd A Lydic, Diana L Takahashi, Jon D Hennebold, Hanne M Hoffmann, Jianrong Wang, Aritro Sen. Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS Mice. Endocrinology 2022; 163(10) doi: 10.1210/endocr/bqac127
|
| 41 |
Georgios S. Papaetis, Panagiota K. Filippou, Kiriaki G. Constantinidou, Christina S. Stylianou. Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome. Clinical Drug Investigation 2020; 40(8): 695 doi: 10.1007/s40261-020-00942-2
|
| 42 |
Danalea V Skarra, Angelina Hernández-Carretero, Alissa J Rivera, Arya R Anvar, Varykina G Thackray. Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance. Endocrinology 2017; 158(9): 2988 doi: 10.1210/en.2016-1898
|
| 43 |
Sai-Hua Zheng, Xue-Lian Li. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. Gynecological Endocrinology 2016; 32(3): 177 doi: 10.3109/09513590.2015.1111327
|
| 44 |
Sultana Marufa Shefin, Rezwana Sobhan, Nazmul Kabir Qureshi. Metabolic and Hormonal Parameters in Polycystic Ovary Syndrome: A Cross-sectional, Multicenter Study in Bangladesh. Bangladesh Journal of Endocrinology and Metabolism 2024; 3(3): 102 doi: 10.4103/bjem.bjem_11_24
|
| 45 |
Joon-yeon Kim, Tae-uk Wang, Jong-bong Kim, Byung-cheon Kweon, Kyeong-moog Kim, Jong-ho Lee. Availability of the Fatty-Liver-Disease Quantification Technique Using MRI : Comparison of Screening Dixon, Multi Echo Dixon, HISTO, and Ultrasonography. Journal of the Korean Society of MR Technology 2017; 27(1): 13 doi: 10.31159/ksmrt.2017.27.1.13
|
| 46 |
Mohamed Shengir, Srinivasan Krishnamurthy, Peter Ghali, Marc Deschenes, Philip Wong, Tianyan Chen, Giada Sebastiani. Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome. World Journal of Gastroenterology 2020; 26(44): 7046-7060 doi: 10.3748/wjg.v26.i44.7046
|
| 47 |
Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Korale Gedara Dayaratne, Farika Nirmani De Silva, Jagath Keerthi Premadasa, Suneth Buddhika Agampodi. Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo). BMJ Open Gastroenterology 2022; 9(1): e000831 doi: 10.1136/bmjgast-2021-000831
|
| 48 |
Mohammad Maysara Asfari, Muhammad Talal Sarmini, Firas Baidoun, Yasser Al-Khadra, Yamen Ezaizi, Srinivasan Dasarathy, Arthur McCullough. Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome. BMJ Open Gastroenterology 2020; 7(1): e000352 doi: 10.1136/bmjgast-2019-000352
|
| 49 |
Tsung-Sheng Chen, Yi-Ting Chen, Chia-Hsin Liu, Chi-Ching Sun, Frank Chiahung Mao. Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS. Gynecological Endocrinology 2017; 33(1): 48 doi: 10.1080/09513590.2016.1205579
|
| 50 |
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis. World Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
|
| 51 |
Erdinc Gulumsek, Burcak Cakir Pekoz, Ayse Selcan Koc, Muhammed Zubeyir Aslan, Huseyin Ali Ozturk, Fatih Necip Arici, Hilmi Erdem Sumbul. Liver Stiffness Is Increased in Polycystic Ovary Syndrome and Related With Complement C1q/Tumor Necrosis Factor–Related Protein 3 Levels. Ultrasound Quarterly 2021; 37(2): 133 doi: 10.1097/RUQ.0000000000000537
|
| 52 |
Mahrukh Shahbaz, Halah Almatooq, Paul Foucambert, Faith D Esbrand, Sana Zafar, Venkatesh Panthangi, Adrienne R Cyril Kurupp, Anjumol Raju, Gaurav Luthra, Safeera Khan. A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome. Cureus 2022; doi: 10.7759/cureus.29928
|
| 53 |
Christian S. Göbl, Johannes Ott, Latife Bozkurt, Michael Feichtinger, Victoria Rehmann, Anna Cserjan, Maike Heinisch, Helmut Steinbrecher, Ivica JustKukurova, Radka Tuskova, Michael Leutner, Elisabeth Vytiska-Binstorfer, Christine Kurz, Andrea Weghofer, Andrea Tura, Christian Egarter, Alexandra Kautzky-Willer, Andrew Wolfe. To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS. PLOS ONE 2016; 11(8): e0160571 doi: 10.1371/journal.pone.0160571
|
| 54 |
R. A. Condorelli, A. E. Calogero, M. Di Mauro, L. M. Mongioi’, R. Cannarella, G. Rosta, S. La Vignera. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. Journal of Endocrinological Investigation 2018; 41(4): 383 doi: 10.1007/s40618-017-0762-3
|
| 55 |
Paulina Vidal-Cevallos, Alejandra Mijangos-Trejo, Misael Uribe, Norberto Chávez Tapia. The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 533 doi: 10.1016/j.ecl.2023.01.005
|
| 56 |
Natalia Zeber-Lubecka, Maria Kulecka, Katarzyna Suchta, Michalina Dąbrowska, Michał Ciebiera, Ewa E. Hennig. Association of Mitochondrial Variants with the Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis. Antioxidants 2023; 12(11): 1983 doi: 10.3390/antiox12111983
|
| 57 |
Amarjeet Singh, Shalini Gainder, Pradipta Banerjee, Apurva Goel, Pawan Kumar, Banashree Mondal, Samudra P. Banik, Debasis Bagchi. Efficacy of a Proprietary Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): a Randomized, Double-Blind, Placebo-Controlled Study. Journal of the American Nutrition Association 2023; 42(7): 651 doi: 10.1080/27697061.2022.2126410
|
| 58 |
Komei Iwai, Tetsuji Azuma, Takatoshi Yonenaga, Yasuyuki Sasai, Kazutoshi Watanabe, Fumiko Deguchi, Akihiro Obora, Takao Kojima, Takaaki Tomofuji. Relationship between Chewing Status and Fatty Liver Diagnosed by Liver/Spleen Attenuation Ratio: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 20(1): 307 doi: 10.3390/ijerph20010307
|
| 59 |
Binghan Jin, Zhaoyuan Wu, Shan Wang, Zhu Yu, Rahim Ullah, Xinyi Liang, Wei Wu, Ke Huang, Yan Ni, Jianbing Wang, Guanping Dong, Junfen Fu. Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study. Hepatology International 2024; 18(1): 179 doi: 10.1007/s12072-023-10596-9
|
| 60 |
Phiwayinkosi V. Dludla, Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, Tawanda M. Nyambuya, Fabio Marcheggiani, Ilenia Cirilli, Khanyisani Ziqubu, Samukelisiwe C. Shabalala, Rabia Johnson, Johan Louw, Elisabetta Damiani, Luca Tiano. N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the Literature. Antioxidants 2020; 9(12): 1283 doi: 10.3390/antiox9121283
|
| 61 |
Adjoa Osei-Ntansah, Trinitee Oliver, Taylor Lofton, Claire Falzarano, Kiana Carr, Ruthe Huang, Andre Wilson, Ella Damaser, Guyton Harvey, Md Ahasanur Rahman, Stanley Andrisse. Liver Androgen Receptor Knockout Improved High-fat Diet Induced Glucose Dysregulation in Female Mice But Not Male Mice. Journal of the Endocrine Society 2024; 8(4) doi: 10.1210/jendso/bvae021
|
| 62 |
Giselle Adriana Abruzzese, Maria Florencia Heber, Silvana Rocio Ferreira, Leandro Martin Velez, Roxana Reynoso, Omar Pedro Pignataro, Alicia Beatriz Motta. Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism. Journal of Endocrinology 2016; 230(1): 67 doi: 10.1530/JOE-15-0471
|
| 63 |
Hafeja Akhter Hima, Md Abdul Hannan Miah, Nipa Rani Ghosh, Sazia Sultana, Tanjina Akter, Fatema Tuz Zahura Aalpona, A. B. M. Kamrul-Hasan. Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome. Bangladesh Journal of Endocrinology and Metabolism 2023; 2(2): 80 doi: 10.4103/bjem.bjem_10_23
|
| 64 |
Marzieh Saei Ghare Naz, Vida Ghasemi, Shabahang Amirshekari, Fahimeh Ramezani Tehrani. Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?. Endocrinology, Diabetes & Metabolism 2024; 7(2) doi: 10.1002/edm2.477
|
| 65 |
Yuying Wang, Xiaojing Guo, Wendi Xu, Jie Cai, Yi Zhang, Chunhua Wu, Shengxian Li, Yun Sun, Wei Liu, Tao Tao. Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous?. Endocrine Practice 2020; 26(9): 1003 doi: 10.4158/EP-2019-0407
|
| 66 |
Peng Cui, Wei Hu, Tong Ma, Min Hu, Xiaoyu Tong, Feifei Zhang, Jiemei Shi, Xiaoqing Xu, Xin Li, Linus Ruijin Shao, Håkan Billig, Yi Feng. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats. The Journal of Steroid Biochemistry and Molecular Biology 2021; 208: 105829 doi: 10.1016/j.jsbmb.2021.105829
|
| 67 |
Natalia Zeber-Lubecka, Michał Ciebiera, Ewa E. Hennig. Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside. International Journal of Molecular Sciences 2023; 24(18): 14126 doi: 10.3390/ijms241814126
|
| 68 |
Hassan Malekinejad, Shima Zeynali-Moghaddam, Ali Rezaei-Golmisheh, Aylar Alenabi, Faezeh Malekinejad, Arash Alizadeh, Vahid Shafie-Irannejad. Lupeol attenuated the NAFLD and PCOS-induced metabolic, oxidative, hormonal, histopathological, and molecular injuries in mice. Research in Pharmaceutical Sciences 2023; 18(5): 551 doi: 10.4103/1735-5362.383710
|
| 69 |
Saqib Hassan, Marika A. Kaakinen, Harmen Draisma, Liudmila Zudina, Mohd A. Ganie, Aafia Rashid, Zhanna Balkhiyarova, George S. Kiran, Paris Vogazianos, Christos Shammas, Joseph Selvin, Athos Antoniades, Ayse Demirkan, Inga Prokopenko. Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome. Genes 2022; 13(2): 379 doi: 10.3390/genes13020379
|
| 70 |
F. Coperchini, P. Leporati, M. Rotondi, L. Chiovato. Expanding the therapeutic spectrum of metformin: from diabetes to cancer. Journal of Endocrinological Investigation 2015; 38(10): 1047 doi: 10.1007/s40618-015-0370-z
|
| 71 |
Kristina R. Chacko, John Reinus. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2016; 20(2): 387 doi: 10.1016/j.cld.2015.10.004
|
| 72 |
Miguel Malespin, Ammar Nassri. Endocrine Diseases and the Liver. Clinics in Liver Disease 2019; 23(2): 233 doi: 10.1016/j.cld.2018.12.006
|
| 73 |
Shakeela Khalid, Muhammad Arshad, Komal Raza, Shahid Mahmood, Farzana Siddique, Nida Aziz, Sarfraz Khan, Waseem Khalid, Ammar AL‐Farga, Faisal Aqlan. Assessment of hepatoprotective, nephroprotective efficacy, and antioxidative potential of Moringa oleifera leaf powder and ethanolic extract against PCOS‐induced female albino mice (Mus Musculus). Food Science & Nutrition 2023; 11(11): 7206 doi: 10.1002/fsn3.3646
|
| 74 |
A. J. Krentz, K. Fujioka, M. Hompesch. Evolution of pharmacological obesity treatments: focus on adverse side‐effect profiles. Diabetes, Obesity and Metabolism 2016; 18(6): 558 doi: 10.1111/dom.12657
|
| 75 |
Tianhe Li, Tingting Zhang, Tianyu Cui, Yuxi Yang, Ruixia Liu, Yi Chen, Chenghong Yin. Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome. The Journal of Steroid Biochemistry and Molecular Biology 2020; 204: 105752 doi: 10.1016/j.jsbmb.2020.105752
|
| 76 |
Stephanie E. Areloegbe, Oluwagbemisola A. Oyekanmi, Isaac O. Ajadi, Mary B. Ajadi, Chukwubueze L. Atuma, Ayodeji Aturamu, Kehinde S. Olaniyi. Hepatic dysmetabolism in polycystic ovarian syndrome: impact of paraoxonase-1 modulation by butyrate. Comparative Clinical Pathology 2024; 33(4): 623 doi: 10.1007/s00580-024-03580-8
|
| 77 |
Kelly N Z Fuller, Julie Allen, Roshan Kumari, Jephte Y Akakpo, Meghan Ruebel, Kartik Shankar, John P Thyfault. Pre– and Post–Sexual Maturity Liver-specific ERα Knockout Does Not Impact Hepatic Mitochondrial Function. Journal of the Endocrine Society 2023; 7(6) doi: 10.1210/jendso/bvad053
|
| 78 |
Pushplata Sankhwar, S. P. Jaiswar, Sonali Yadav, Vandana Awasthi, Apurva Goel, Pawan Kumar, Samudra P. Banik, Manashi Bagchi, Debasis Bagchi. Beneficial Effects of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): A Follow-up Compliance Clinical Investigation. Journal of the American Nutrition Association 2023; 42(7): 691 doi: 10.1080/27697061.2022.2145526
|
| 79 |
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
|
| 80 |
ShanHu Gao, Fei Long, Zheng Jiang, Jun Shi, DongXue Ma, Yang Yang, Jin Bai, Ting-Li Han. The complex metabolic interactions of liver tissue and hepatic exosome in PCOS mice at young and middle age. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.990987
|
| 81 |
Nasser Alorfi, Ahmed Ashour. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry. Diabetes, Metabolic Syndrome and Obesity 2023; : 3115 doi: 10.2147/DMSO.S430740
|
| 82 |
Ishfaq Hassan Mir, Saqib Hassan, Joseph Selvin, Chinnasamy Thirunavukkarasu. Human Microbiome in Health, Disease, and Therapy. 2023; : 127 doi: 10.1007/978-981-99-5114-7_7
|
| 83 |
Fan Hong, Pengfei Xu, Yonggong Zhai. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 2018; 19(8): 2189 doi: 10.3390/ijms19082189
|
| 84 |
Fahimeh Shams, Monireh Aghajani-nasab, Mahsa Ramezanpour, Razieh Habibipour Fatideh, Fahimeh Mohammadghasemi. Effect of apple vinegar on folliculogenesis and ovarian kisspeptin in a high-fat diet-induced nonalcoholic fatty liver disease in rat. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01205-1
|
| 85 |
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim. Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(2): 221 doi: 10.3350/cmh.2020.0239
|
| 86 |
Aimé Florencia Silva, Giselle Adriana Abruzzese, María José Ferrer, María Florencia Heber, Silvana Rocío Ferreira, Gloria Edith Cerrone, Alicia Beatriz Motta. Fetal programming by androgen excess impairs liver lipid content and PPARg expression in adult rats. Journal of Developmental Origins of Health and Disease 2022; 13(3): 300 doi: 10.1017/S2040174421000416
|
| 87 |
Yi Tan, Xing Liang Jin, Weiguo Lao, Jane Kim, Linda Xiao, Xianqin Qu. Antiresistin RNA Oligonucleotide Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Attenuating Proinflammatory Cytokines. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/414860
|
| 88 |
Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome. Indian Journal of Medical Research 2020; 151(4): 333 doi: 10.4103/ijmr.IJMR_610_18
|
| 89 |
Abhaya Krishnan, Sridhar Muthusami, Loganayaki Periyasamy, Jone A. Stanley, Vasudevan Gopalakrishnan, Ilangovan Ramachandran. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology. Medicina 2020; 56(3): 100 doi: 10.3390/medicina56030100
|
| 90 |
Unaiza Qamar, Stephen L. Atkin, Thozhukat Sathyapalan. Practical Guide to Obesity Medicine. 2018; : 59 doi: 10.1016/B978-0-323-48559-3.00006-3
|
| 91 |
E Vassilatou, D A Vassiliadi, K Salambasis, H Lazaridou, N Koutsomitopoulos, N Kelekis, D Kassanos, D Hadjidakis, G Dimitriadis. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease. European Journal of Endocrinology 2015; 173(6): 739 doi: 10.1530/EJE-15-0567
|
| 92 |
Timothy Wang, Wei Yang, Sidika Karakas, Souvik Sarkar. NASH in Nondiabetic Endocrine Disorders. Metabolic Syndrome and Related Disorders 2018; 16(7): 315 doi: 10.1089/met.2018.0044
|
| 93 |
Gulnara Novbatova, Isabelle Fox, Kelsey Timme, Aileen F Keating. High fat diet-induced obesity and gestational DMBA exposure alter folliculogenesis and the proteome of the maternal ovary. Biology of Reproduction 2024; 111(2): 496 doi: 10.1093/biolre/ioae070
|
| 94 |
Muraly Puttabyatappa, Vasantha Padmanabhan. Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome. Journal of Molecular Endocrinology 2018; 61(4): R161 doi: 10.1530/JME-18-0079
|
| 95 |
Richie Manikat, Mindie H. Nguyen. Nonalcoholic fatty liver disease and non-liver comorbidities. Clinical and Molecular Hepatology 2023; 29(Suppl): s86 doi: 10.3350/cmh.2022.0442
|
| 96 |
Rosita A. Condorelli, Aldo E. Calogero, Maurizio Di Mauro, Sandro La Vignera. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution. Gynecological Endocrinology 2017; 33(9): 665 doi: 10.1080/09513590.2017.1342240
|
| 97 |
Rui Han, Xiaoyun Gong, Yuejie Zhu, Xiaoran Liu, Yan Xia, Yuhong Huang, Meng Zhang, Yunian Zhang, Xiaolin La, Jianbing Ding, Silvia Gregori. Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9596358
|
| 98 |
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
|
| 99 |
Giuliana Motta, Soundara Viveka Thangaraj, Vasantha Padmanabhan. Developmental Programming: Impact of Prenatal Exposure to Bisphenol A on Senescence and Circadian Mediators in the Liver of Sheep. Toxics 2023; 12(1): 15 doi: 10.3390/toxics12010015
|
| 100 |
Stanley Andrisse, Mingxiao Feng, Zhiqiang Wang, Olubusayo Awe, Lexiang Yu, Haiying Zhang, Sheng Bi, Hongbing Wang, Linhao Li, Serene Joseph, Nicola Heller, Franck Mauvais‐Jarvis, Guang William Wong, James Segars, Andrew Wolfe, Sara Divall, Rexford Ahima, Sheng Wu. Androgen‐induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females. The FASEB Journal 2021; 35(10) doi: 10.1096/fj.202100961R
|
| 101 |
Monika Sarkar, Melissa Wellons, Marcelle I Cedars, Lisa VanWagner, Erica P Gunderson, Veeral Ajmera, Laura Torchen, David Siscovick, Jeffrey J Carr, James G Terry, Mary Rinella, Cora E Lewis, Norah Terrault. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. American Journal of Gastroenterology 2017; 112(5): 755 doi: 10.1038/ajg.2017.44
|
| 102 |
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, Tom Houben. Prevention and Treatment of Atherosclerosis. Handbook of Experimental Pharmacology 2020; 270: 233 doi: 10.1007/164_2020_352
|
| 103 |
Agata Łukawska, Marcin Kałużny, Sonia Nogalska, Eliza Kubicka, Justyna Kuliczkowska-Płaksej, Marek Bolanowski. Polycystic ovary syndrome and non-alcoholic fatty
liver disease: Matched pair or sporadic coexistence?. Postępy Higieny i Medycyny Doświadczalnej 2020; 74: 377 doi: 10.5604/01.3001.0014.3920
|
| 104 |
Yvonne M. Jeanes, Sue Reeves. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutrition Research Reviews 2017; 30(1): 97 doi: 10.1017/S0954422416000287
|
| 105 |
Shikha Rani, Piyush Chandna. Multiomics Analysis–Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome. Reproductive Sciences 2023; 30(1): 1 doi: 10.1007/s43032-022-00863-9
|
| 106 |
Nazia Begum, Kandavalli Manipriya, B. Veeresh. Role of high-fat diet on letrozole-induced polycystic ovarian syndrome in rats. European Journal of Pharmacology 2022; 917: 174746 doi: 10.1016/j.ejphar.2022.174746
|
| 107 |
Annie Chen, Alex Handzel, Lillian Sau, Laura Cui, Scott T. Kelley, Varykina G. Thackray. Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice. Endocrinology, Diabetes & Metabolism 2024; 7(1) doi: 10.1002/edm2.443
|
| 108 |
Maasoume Abdollahi, Seyed Mahdi Mirghazanfari, Mozhgan Mehri. Investigating the Possible Ameliorating Impact of Black Seed (Nigella sativa) Hydroethanolic Extract on Liver and Brain Tissue in a Rat Model of Polycystic Ovary. Annals of Military and Health Sciences Research 2024; 22(2) doi: 10.5812/amh-147832
|
| 109 |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Complicaciones extrahepáticas de la enfermedad por hígado graso no alcohólico: impacto más allá del hígado. Revista de Gastroenterología de México 2019; 84(4): 472 doi: 10.1016/j.rgmx.2019.05.004
|
| 110 |
Sinéad M. McGlacken-Byrne, Harriet M. Gunn, Helen Simpson. Paediatric Endocrinology. Endocrinology 2024; : 619 doi: 10.1007/978-3-030-23709-7_29
|
| 111 |
Linlin Fu, Yexing Li, Yuehong Bian, Qiumin Wang, Jingyu Li, Ying Wang, Tiantian Zhang, Xiaoyan Zou, Linlin Cui, Zijiang Chen. The Nutritional Intervention Improves the Metabolic Profile of Overweight and Obese PCOS Along with the Differences in Gut Microbiota. Reproductive Sciences 2023; 30(7): 2210 doi: 10.1007/s43032-022-01131-6
|
| 112 |
Diego A. Miranda, William C. Krause, Amaury Cazenave-Gassiot, Miyuki Suzawa, Hazel Escusa, Juat Chin Foo, Diyala S. Shihadih, Andreas Stahl, Mark Fitch, Edna Nyangau, Marc Hellerstein, Markus R. Wenk, David L. Silver, Holly A. Ingraham. LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. JCI Insight 2018; 3(5) doi: 10.1172/jci.insight.96151
|
| 113 |
Yoseph Asmelash Gebru, Haripriya Gupta, Hyeong Seop Kim, Jung A. Eom, Goo Hyun Kwon, Eunju Park, Jin-Ju Jeong, Sung-Min Won, Satya Priya Sharma, Raja Ganesan, Dong Joon Kim, Ki Tae Suk. T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(22): 12190 doi: 10.3390/ijms222212190
|
| 114 |
Dariusz Szukiewicz, Seweryn Trojanowski, Anna Kociszewska, Grzegorz Szewczyk. Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors. International Journal of Molecular Sciences 2022; 23(23): 14663 doi: 10.3390/ijms232314663
|
| 115 |
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2021; : 157 doi: 10.1007/978-3-319-68729-2_6
|
| 116 |
Ana Maria Singeap, Laura Huiban. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 183 doi: 10.1007/978-3-031-33548-8_16
|
| 117 |
Varykina G. Thackray. Sex, Microbes, and Polycystic Ovary Syndrome. Trends in Endocrinology & Metabolism 2019; 30(1): 54 doi: 10.1016/j.tem.2018.11.001
|
| 118 |
Suliman Al Humayed. Protective and therapeutic effects ofCrataegus aroniain non-alcoholic fatty liver disease. Archives of Physiology and Biochemistry 2017; 123(1): 23 doi: 10.1080/13813455.2016.1205097
|
| 119 |
Shih-Yi Lin, Yu-Cih Yang, Cherry Yin-Yi Chang, Cheng-Chieh Lin, Wu-Huei Hsu, Shu-Woei Ju, Chung-Y. Hsu, Chia-Hung Kao. Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis. International Journal of Environmental Research and Public Health 2019; 16(23): 4816 doi: 10.3390/ijerph16234816
|